This product is lyophilized and requires reconstitution. It comes with a home kit.

Tirzepatide is a once-weekly injectable medication that acts as a dual GIP and GLP-1 receptor agonist. It regulates insulin secretion, slows gastric emptying, and reduces appetite. Clinical studies show that Tirzepatide significantly improves blood sugar control and supports substantial, sustainable weight loss when used under medical supervision. This higher-concentration formulation is intended for patients on advanced maintenance dosing.

Benefits

Promotes significant and sustainable weight loss
Improves blood glucose regulation and insulin sensitivity
Reduces appetite and food cravings
Supports cardiovascular and metabolic health

Estimated duration is based on dosing protocol, for questions contact Patient Support at +1 (888) 471-9962.

Hot on the Market